Whole Blood
Whole Blood is a biological therapy with 10 clinical trials. Currently 1 active trials ongoing. Historical success rate of 57.1%.
Success Metrics
Based on 4 completed trials
Phase Distribution
Phase Distribution
0
Early Stage
1
Mid Stage
3
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
57.1%
4 of 7 finished
42.9%
3 ended early
1
trials recruiting
10
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
SWiFT Canada (Study of Whole Blood in Frontline Trauma)
Early Use of Cryoprecipitate With Major Hemorrhage Protocol (MHP) Activation
Circulating Tumor DNA Study in Patients With Endometrial Cancer
Pragmatic Prehospital Group O Whole Blood Early Resuscitation Trial
Whole Blood Specimen Collection From Healthy Subjects
Clinical Trials (10)
SWiFT Canada (Study of Whole Blood in Frontline Trauma)
Early Use of Cryoprecipitate With Major Hemorrhage Protocol (MHP) Activation
Circulating Tumor DNA Study in Patients With Endometrial Cancer
Pragmatic Prehospital Group O Whole Blood Early Resuscitation Trial
Whole Blood Specimen Collection From Healthy Subjects
Platelet-rich Plasma vs. Whole Blood for Gluteus Medius Tendinopathy
Predictive Value of the Immune Response of the Host in Clostridium Difficile Infections
Use of Brain Oxygen Tension Level and Cleaved-tau Protein to Detect Vasospasm After SAH
Study of Safe Blood Transfusion Volumes to Correct Acute Severe Anaemia
Diagnostic Interest of Leukocyte Immunophenotyping Using Multiparameter 8-color Flow Cytometry in Heart Surgery
All 10 trials loaded
Drug Details
- Intervention Type
- BIOLOGICAL
- Total Trials
- 10